Sulixin(Adalimumab) Injection
Product name/English name: SULINNO, generic name Adalimumab Injection
Production unit: Xinda Biopharmaceutical (Suzhou) Co., Ltd
Approval number: National Medical Products Administration Approval Number S20200020
Common specifications: 40mg/0.8mL, 80mg/0.8mL, 100mg/1mL. The active ingredients, efficacy, and safety are completely consistent with traditional penicillin bottle formulations
What is Adalimumab Sulixin?
Adalimumab Sulixin is a TNF inhibitor that treats various autoimmune diseases by inhibiting the action of tumor necrosis factor (TNF). It is a biological agent that is a monoclonal antibody prepared through genetic engineering technology. It can interfere with signal transduction during the inflammatory response process, reducing tissue damage and symptoms caused by inflammation.
2. Indications
Adalimumab Sulixin is suitable for the treatment of various autoimmune diseases, including rheumatoid arthritis, ankylosing spondylitis, psoriasis, Crohn’s disease, and idiopathic arthritis. These diseases are caused by inflammatory reactions resulting from abnormal activation of the immune system. Adalimumab can inhibit these inflammatory reactions, alleviate symptoms, and improve patients’ quality of life.
3. Usage and precautions
3.1 Instructions for use
Adalimumab Sulixin is usually used in the form of an injection. The use and dosage of syringes should be based on the doctor’s advice. It can be injected subcutaneously or intramuscularly, and the specific dosage and injection frequency will depend on the type of disease and the specific condition of the patient.
3.2 Precautions
Before using Adalimumab Sulixin, patients should inform their doctors about their medical history, allergic reactions, and other medications being used. For some patients at risk of infection, the use of adalimumab may increase the risk of infection, so special attention should be paid to the signs of infection during use and timely medical attention should be sought. During the treatment period, regular blood routine and liver function tests are conducted to ensure the safe use of the medication.
4. Adverse reactions
There may be some adverse reactions when using Adalimumab Sulixin. The most common adverse reactions include pain, erythema, and edema at the injection site. A small number of patients may experience symptoms such as headache, nausea, vomiting, and fatigue. Serious adverse reactions include infection, allergic reactions, and immune system abnormalities, but these situations are relatively rare. If patients experience the aforementioned adverse reactions or other discomforts during the use of adalimumab, they should promptly inform their doctors.
